CryoPort, Inc. Common Stock
CYRXStock
$16.49+126.06%52W
Market Cap$826.22M
P/E10.55x
Div yield—
Beta1.89
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)45.98%
Price vs S&P 500 (4W)12.05%
VGM Score64.68
Market Capitalization$826.22M
P/E Ratio (Annual)10.55x
Earnings Surprise History
Q1 26-0.25est. -0.22
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.25
4.25
4.25
4.25
Industry Peers — Pharmaceuticals(563)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
CYRXCryoPort, Inc. Common Stock | C | C | A | $16.49 |
| LLYEli Lilly & Co. | D | B | B | $1169.17 |
| JNJJohnson & Johnson | D | C | B | $249.97 |
| ABBVABBVIE INC. | D | C | B | $254.39 |
| MRKMerck & Co., Inc. | C | C | B | $127.63 |
| NVSNovartis AG | C | C | C | $152.73 |
| NVONovo-Nordisk A/S | C | B | C | $51.48 |
| AZNAstraZeneca PLC | C | B | C | $169.29 |
| ABTAbbott Laboratories | C | C | D | $98.83 |
| PFEPfizer Inc. | B | C | C | $25.14 |
| VRTXVertex Pharmaceuticals Inc | D | C | C | $486.03 |
About
Cryoport is a provider of integrated temperature-controlled logistics and products for the life sciences industry, serving biopharmaceutical, pharmaceutical, animal health, and reproductive medicine markets. The company operates two business segments: Life Sciences Services and Life Sciences Products. With global operations across the Americas, Europe, the Middle East, Africa, and Asia Pacific, Cryoport generates the majority of its revenue from North American operations.